Susan Weaver Acquires Shares in AdaptHealth Corp.

Susan Weaver, an insider at AdaptHealth Corp., bought 18,999 shares of the company on June 24, 2026. The purchase did not specify a transaction price, but shares of AdaptHealth traded near $10.18 on that day. This transaction adds to Weaver's stake in the company, highlighting insider confidence.

Insider Buying and Selling at AdaptHealth Corp.

Several insiders at AdaptHealth Corp. made notable transactions recently. On the same day as Weaver's purchase, David Solomon Williams III also bought 18,999 shares. Earlier, on June 1, 2026, Russell Schuster III, the Chief Commercial Officer, sold 11,275 shares at an average price of $10.06 under a planned sale. Daniel Edward McFadden, the Chief Operating Officer, acquired 20,134 shares on May 27, 2026.

Other Institutional Activity in AdaptHealth Corp.

OEP Capital Advisors, L.P. increased its holdings in AdaptHealth by 2,494,518 shares, bringing its total to 16,312,698 shares worth about $194.1 million, marking an 18.1% increase. BlackRock, Inc. added 247,939 shares to its position, totaling 15,939,953 shares valued at approximately $189.7 million, reflecting a 1.6% increase. Reinhart Partners, LLC. also boosted its stake by 1,981,198 shares to 10,081,983 shares, valued at roughly $120 million, representing a 24.5% increase.

AdaptHealth Corp. Stock Up 77.7%

On Saturday, shares of AdaptHealth Corp. (NasdaqCM:AHCO) traded near $10.18. The company has a market capitalization of approximately $1.4 billion and a forward P/E ratio of 8.75. The stock's 52-week range is between $8.51 and $13.43, with a 50-day moving average of $10.99 and a 200-day moving average of $10.21. AdaptHealth has a beta of 1.463, indicating higher volatility compared to the broader market.

Analysts Set New Price Targets

Several analysts have maintained their positive outlook on AdaptHealth. On May 11, 2026, RBC Capital reaffirmed its buy rating with a price target of $15. Similarly, Canaccord Genuity and UBS maintained buy ratings with targets of $16 and $14, respectively, on May 6, 2026. The consensus among eight analysts is a buy recommendation, with an average price target of $14.

About AdaptHealth Corp.

AdaptHealth Corp. distributes home medical equipment and supplies across the United States. It operates through segments like Sleep Health and Respiratory Health, offering equipment for sleep apnea, diabetes management, and more. Founded in 2012 and headquartered in Conshohocken, Pennsylvania, the company employs about 10,900 people. Suzanne M. Foster serves as the CEO, leading AdaptHealth's efforts to provide services to Medicare, Medicaid, and commercial insurance beneficiaries.

Bottom Line

Susan Weaver's recent purchase of AdaptHealth shares signals ongoing insider interest in the company. With a solid market presence and analyst backing, AdaptHealth remains a stock to watch. Remember, insider transactions are disclosed after the fact, providing insights but not necessarily indicating future performance.